Skip to search.
 STI Down 0.31%

Biogen Inc. (BIIB)

-NasdaqGS
297.19 Up 1.41(0.48%) 3 Dec 05:00 SGT
Prev Close:295.78
Open:296.53
Bid:297.20 x 100
Ask:307.62 x 200
1y Target Est:338.22
Beta:0.416956
Earnings Date:25 Jan - 30 Jan (Est.)
Day's Range:293.04 - 299.95
52wk Range:223.02 - 333.65
Volume:1,429,360
Avg Vol (3m):1,540,120
Market Cap:64.66B
P/E (ttm):16.81
EPS (ttm):17.68
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
BIIBUp 0.48%64.66B
PFEUp 0.54%191.94B
ABTUp 0.80%55.80B

Key Statistics

Forward P/E (1 yr):14.26
P/S (ttm):5.64
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :20.20
Quarterly EPS Est (Dec-16) :4.99
Mean Recommendation*:2.0
PEG Ratio (5 yr expected):1.64

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Biogen Inc. discovers, develops, manufactures, and delivers therapies for the treatment of neurodegenerative diseases, hematologic conditions, and autoimmune disorders. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback